Indigenous Bloom Hemp Corp VRTHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–1.00
- Bid/Ask
- $0.00 / $1.00
- Market Cap
- $71.14
- Volume/Avg
- 1,125 / 799
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Indigenous Bloom Hemp Corp is in business to produce and sell hemp extracts. It is engaged in the farming and cultivation of hemp biomass for third-party processing to extract cannabidiol (CBD) oils, distillate or isolate. The resulting solution can then be used for the production of many CBD products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
Valuation
Metric
|
VRTHF
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
VRTHF
|
---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.05 |
Interest Coverage | −1,130.37 |
Quick Ratio
VRTHF
Profitability
Metric
|
VRTHF
|
---|---|
Return on Assets (Normalized) | −173.40% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
VRTHF
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Dphcwmxnw | Xnl | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Wkspxxqb | Zsfmqst | $68.1 Bil | |
HLN
| Haleon PLC ADR | Hcrvjrzf | Hsrkl | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Gqpjxll | Wjqm | $14.3 Bil | |
VTRS
| Viatris Inc | Ydsxpfdnh | Ttg | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Nqqlhmjzt | Jdyl | $12.0 Bil | |
CTLT
| Catalent Inc | Lmqggcbc | Fdhvx | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Tctjtgs | Ftssj | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Lpdwddl | Nmqdb | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hbbkhzdh | Rqgrng | $3.4 Bil |